A two-day Pakistan-China healthcare investment conference opened Friday, bringing together leading Pakistani pharmaceutical, health care and biotechnology companies with Chinese investors, manufacturers, technology providers and industry leaders.
Addressing the Pakistan-China B2B Investment Conference on the pharmaceutical, healthcare and biotechnology sectors here, Pakistani Prime Minister Shehbaz Sharif said that the event will provide a significant platform for strengthening collaboration between the pharmaceutical industries of Pakistan and China.
The B2B agreements signed between Pakistani and Chinese companies during the event mark another important step in advancing cooperation under the China-Pakistan Economic Corridor (CPEC) 2.0, according to him.
He said it would encourage private-sector partnerships in the co-production of medicines, vaccines, and other life-saving healthcare products while opening new avenues for investment and industrial cooperation. — Xinhua
#TheGlobalNewLightOfMyanmar